Mahmood Jeddi-Tehrani Selected Research

Mahmood Jeddi-Tehrani Research Topics

Disease

43	Neoplasms (Cancer) 06/2022 - 01/2007
18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2015 - 02/2003
13	Breast Neoplasms (Breast Cancer) 02/2020 - 04/2009
9	Infections 01/2022 - 05/2014
8	Tetanus 10/2021 - 06/2007
7	Whooping Cough (Pertussis) 01/2018 - 06/2007
7	Spontaneous Abortion (Miscarriage) 07/2017 - 04/2006
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2015 - 06/2005
6	Carcinoma (Carcinomatosis) 12/2015 - 07/2009
5	Hepatitis B 10/2021 - 09/2013
5	Habitual Abortion (Recurrent Miscarriage) 10/2015 - 08/2010
4	Testicular Neoplasms (Testicular Cancer) 01/2020 - 05/2014
4	Leukemia 01/2014 - 02/2003
4	Hematologic Neoplasms (Hematological Malignancy) 04/2013 - 01/2010
3	COVID-19 01/2022 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 05/2019 - 01/2004
3	Infertility (Sterility) 01/2019 - 04/2006
3	Ovarian Neoplasms (Ovarian Cancer) 08/2018 - 12/2009
3	Endometriosis 09/2014 - 06/2008
3	Diphtheria 06/2013 - 06/2007
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2011 - 06/2005
2	Spasm (Spasms) 10/2021 - 02/2020
2	Cutaneous Leishmaniasis 01/2020 - 12/2017
2	Prostatic Neoplasms (Prostate Cancer) 07/2019 - 01/2015
2	Obesity 02/2016 - 10/2012
2	Choroidal Neovascularization 10/2015 - 11/2013
2	Brucellosis (Malta Fever) 11/2014 - 11/2014
2	Communicable Diseases (Infectious Diseases) 01/2014 - 05/2009
2	Thrombophilia 09/2010 - 04/2006
2	Pathologic Processes 08/2010 - 01/2007
1	Chronic Hepatitis B 10/2021
1	Rubella (German Measles) 01/2021

Drug/Important Bio-Agent (IBA)

21	Monoclonal AntibodiesIBA 01/2022 - 04/2009
21	AntigensIBA 12/2021 - 02/2003
14	Proteins (Proteins, Gene)FDA Link 06/2022 - 06/2005
14	AntibodiesIBA 10/2021 - 06/2007
12	VaccinesIBA 01/2021 - 02/2003
9	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2013
9	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2018 - 01/2007
8	EpitopesIBA 06/2022 - 02/2003
5	CytokinesIBA 01/2019 - 06/2008
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 09/2013
4	Peptides (Polypeptides)IBA 01/2022 - 01/2014
4	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 10/2016
4	Biological ProductsIBA 01/2019 - 03/2008
3	EnzymesIBA 01/2022 - 01/2007
3	LigandsIBA 10/2021 - 07/2014
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 09/2010
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2015
3	pertuzumabIBA 01/2021 - 01/2018
3	tetanospasmin (tentoxilysin)IBA 02/2020 - 01/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 12/2014
3	Pharmaceutical PreparationsIBA 11/2018 - 01/2010
3	sortilinIBA 12/2015 - 07/2009
3	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2015 - 04/2006
3	FibromodulinIBA 08/2013 - 06/2005
3	Tumor Biomarkers (Tumor Markers)IBA 03/2013 - 07/2009
3	Pertussis VaccineIBA 01/2013 - 06/2007
3	Messenger RNA (mRNA)IBA 01/2013 - 02/2008
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2008 - 02/2003
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 09/2008
2	ImmunosorbentsIBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2021
2	NeurotoxinsIBA 10/2021 - 03/2020
2	hersintuzumabIBA 01/2021 - 01/2018
2	Carcinoembryonic AntigenIBA 05/2019 - 01/2004
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2019 - 01/2004
2	Docetaxel (Taxotere)FDA Link 11/2018 - 10/2017
2	Fluorescein-5-isothiocyanate (FITC)IBA 08/2018 - 03/2013
2	human ERBB2 proteinIBA 11/2017 - 01/2016
2	hepatitis B hyperimmune globulinIBA 01/2017 - 10/2016
2	Insulin (Novolin)FDA Link 02/2016 - 04/2015
2	Hemagglutinins (Hemagglutinin)IBA 02/2016 - 02/2015
2	Virulence Factors (Pathogenicity Factors)IBA 02/2016 - 02/2015
2	ResveratrolIBA 10/2015 - 10/2013
2	Retinaldehyde (Retinal)IBA 10/2015 - 11/2013
2	Bevacizumab (Avastin)FDA Link 10/2015 - 11/2013
2	Cholecalciferol (Vitamin D3)FDA Link 05/2015 - 09/2011
2	Subunit VaccinesIBA 11/2014 - 11/2014
2	Small Interfering RNA (siRNA)IBA 07/2014 - 01/2013
2	Plasminogen Activator Inhibitor 1IBA 01/2014 - 11/2012
2	IronIBA 10/2013 - 04/2009
2	tyrosine receptor (receptor, tyrosine)IBA 04/2013 - 01/2007
2	Phosphotransferases (Kinase)IBA 04/2013 - 01/2007
2	factor V LeidenIBA 04/2012 - 04/2006
2	Factor XIII (Coagulation Factor XIII)IBA 04/2012 - 09/2010
2	HesperidinIBA 02/2012 - 01/2011
2	hydroxide ionIBA 10/2011 - 09/2011
2	FenretinideIBA 10/2011 - 01/2010
2	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 06/2009 - 06/2007
1	Tetanus ToxinIBA 06/2022
1	Immunodominant EpitopesIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 12/2021
1	Pattern Recognition ReceptorsIBA 10/2021
1	Poly I-CIBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 09/2008
14	Immunotherapy 01/2021 - 01/2007
2	Quantum Dots (Quantum Dot) 08/2018 - 03/2013